Stay updated with breaking news from Supernus Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After U.S. markets close Tuesday afternoon, 113 companies are scheduled to report quarterly earnings results. The following table is based on data from Briefing.com and includes a consensus forecast in dollars for quarterly earnings per share and EPS reported last year, and the consensus forecast for quarterly revenue in thousands of dollars. Companies marked with […]
TOKYO (dpa-AFX) - Following are some biotech stocks that touched new highs yesterday. Were you able to profit from them?1. Cabaletta Bio Inc. (CABA)Cabaletta is a clinical-stage biotechnology company
Jefferies Equity Strategist Steven DeSanctis says these 25 stocks look like bargains after falling on hard times recently.
Supernus Pharmaceuticals Inc said on Monday it would buy Adamas Pharmaceuticals Inc for about $400 million, to expand its roster of treatments for Parkinson's disease and reduce reliance on its top-selling epilepsy medicine.